Health

Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer

SUZHOU, China, Feb. 10, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Michael Shi as Executive Vic...

2021-02-11 08:00 1712

First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study

NYON, Switzerland, Feb. 11, 2021 /PRNewswire/ -- MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD). SELUTION SLR is a novel sirolimus-e...

2021-02-11 08:00 3429

'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance

MELBOURNE, Australia, Feb. 11, 2021 /PRNewswire/ -- SuperTrans Medical (STM), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant bacteria, has published First-In-Class, successful pre-clinical results and announced plans to begin clinica...

2021-02-11 06:00 2491

ICP DAS Biomedical Polymers Announces To Offer Taiwan High-Quality Medical TPU

TAIPEI, Feb, 11, 2021 /PRNewswire/ -- ICP DAS- Biomedical Polymers ("ICP DAS-BMP") is a medical TPU supplier inTaiwan. Today, the company officially announced that it begins to offer its medical thermoplastic polyurethane (TPU) to the medical devices market worldwide.  

2021-02-11 03:17 3716

Care Journey Orchestration Tackles Healthcare's Biggest Operational Challenges

This innovative approach, already used in other industries, helps health systems refactor their costs, shift to be consumer-centric, and make reimbursement predictable, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 11, 2021 /PRNewswire/ -- The economics of healthcare have been adversely affec...

2021-02-11 00:02 2177

Össur will be carbon neutral in 2021

REYKJAVIK, Iceland, Feb. 10, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50th anniversary year. Originally founde...

2021-02-10 23:58 6585

Abbott's Fast, Reliable and Convenient COVID-19 Tests Ramp Up Indonesia's Testing Capability

- Southeast Asia's most populous nation1 expands use of fastest available molecular point-of-care technology and an antigen rapid test device that needs just a nasal swab, to detect active coronavirus infections at massive scale - Delivering reliable results in minutes, Abbott's COVID-19 testing ...

2021-02-10 23:14 8028

VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock

AUSTIN, Texas, Feb. 10, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers ...

2021-02-10 22:18 9441

RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform

SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizesRapidAI with the 2020 Global Growth, Innovation & Leadership Frost Radar Award for its artificial intelligence (AI) and machine lea...

2021-02-10 22:00 2106

BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines

VANCOUVER, BC and BARCELONA, Spain, Feb. 10, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, and Procare Health Iberia, S.L., ofBarcelona, Spain ("Procare Health"...

2021-02-10 21:26 4818

Elekta's ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...

2021-02-10 21:25 6192

I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors

SHANGHAI and GAITHERSBURG, Md., Feb. 10, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China N...

2021-02-10 21:00 5324

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first pati...

2021-02-10 19:51 1986

Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial

BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first pati...

2021-02-10 19:12 1786

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial

* Commitments received for a placement of A$15,991,634 at A$0.145 per share * Significant participation from North American and European institutional and sophisticated investors * This capital raising enables proceeding with the Phase 2b PTSD trial in mid-2021 as planned and sees the Compan...

2021-02-10 19:00 8078

MGI's "Super Sequencer" Helps Sweden's National Pandemic Center Monitor COVID-19 Mutations

STOCKHOLM, Feb. 10, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughoutSweden greatly improve their COVID-19 testing capabilities from the laboratory at the National Pandemic Center located inKarolinska Institute (KI). Sweden's STV Ne...

2021-02-10 18:52 1153

Xi: China ready to cooperate with CEE countries on vaccines

BEIJING, Feb. 10, 2021 /PRNewswire/ -- China Daily: A highlight from President Xi Jinping's keynote speech at the virtual China-CEEC Summit inBeijing, Feb 9, 2021. A highlig...

2021-02-10 17:43 2048

Thailand 2020 Investment Applications at Over 480 Billion Baht, Led by E&E and Food, BOI Says

BANGKOK, Feb. 10, 2021 /PRNewswire/ -- The Thailand Board of Investment (BOI) said today that local and foreign investors had in 2020 filed a total of 1,717 applications for investment promotion, representing a combined investment value of481.1 billion baht (USD16 billion), led by projects in the...

2021-02-10 17:38 2717

CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

CAESAREA, Israel, Feb. 10, 2021 /PRNewswire/ --  CardiacSense  -  a digital health company that developed and clinically verified amedical grade watch  capable of detecting and remotely monitoring Atrial Fibrillation ...

2021-02-10 15:00 2710

Hong Kong public focuses on financial wellbeing, retirement planning and health amid pandemic, Manulife survey shows

* Control of finances more important given concerns about loss of personal wealth * Preference for dealing with agents when buying insurance, although digital on the rise HONG KONG, Feb. 10, 2021 /PRNewswire/ -- A year on from the outbreak of COVID-19,Hong Kong residents are taking more contr...

2021-02-10 13:55 3356
1 ... 657658659660661662663 ... 858